비즈니스 · 2004. 1. 29.1 분 읽기
Determination of Regulatory Review Period for Purposes of Patent Extension; FROVA
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) has determined the regulatory review period for FROVA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of two applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of two patents that claims that human drug product.